Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions

被引:32
|
作者
Murphy, R [1 ]
Green, S
Ritter, G
Cohen, L
Ryan, D
Woods, W
Rubira, M
Cebon, J
Davis, ID
Sjolander, A
Kypridis, A
Kalnins, H
McNamara, M
Moloney, MB
Ackland, J
Cartwright, G
Rood, J
Dumsday, G
Healey, K
Maher, D
Maraskovsky, E
Chen, YT
Hoffman, EW
Old, LJ
Scott, AM
机构
[1] Austin Hosp, Biol Prod Facil, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Heidelberg, Vic 3084, Australia
[2] CSL Ltd, Parkville, Vic, Australia
[3] Ludwig Inst Canc Res, New York Branch, New York, NY USA
来源
关键词
NY-ESO-1; cGMP; cancer-testis antigen; recombinant protein;
D O I
10.1081/PB-200054732
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The cancer-testis antigen, NY-ESO-1, has been engineered into a bacterial expression plasmid which incorporates a His(6)-tag. The plasmid was transfected into E. coli strain BL21 and Master and Working cell banks generated from this expression system. Three 15-litre fermentations were performed under cGMP (code of Good Manufacturing Practice) conditions and the crude NY-ESO-1 tagged protein isolated as solubilised inclusion bodies. A three-step cGMP chromatography process (immobilised metal affinity, anion exchange, and hydrophobic interaction) was utilised to purify the protein. The purified NY-ESO-1 is being used in early stage human cancer vaccine trials in Australia and the U.S.A.
引用
收藏
页码:119 / 134
页数:16
相关论文
共 50 条
  • [1] Expression and Purification of cGMP grade NY-ESO-1 for Clinical Trials
    Lowe, Adam J.
    Bardliving, Cameron L.
    Huang, Chung-Jr
    Teixeira, Leonardo M.
    Damasceno, Leonardo M.
    Anderson, Kyle A.
    Ritter, Gerd
    Old, Lloyd J.
    Batt, Carl A.
    BIOTECHNOLOGY PROGRESS, 2011, 27 (02) : 435 - 441
  • [2] NY-ESO-1 antigen: A promising frontier in cancer immunotherapy
    Alsalloum, Alaa
    Shevchenko, Julia A.
    Sennikov, Sergey
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (09):
  • [3] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [4] Expression of NY-ESO-1 cancer testis antigen in prostate cancer.
    Jain, Rohit K.
    Xu, Bo
    Mehta, Rutika Jitesh
    Pop, Elena
    Mohler, James
    Odunsi, Kunle
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Development of a transient mammalian expression process for the production of the cancer testis antigen NY-ESO-1
    Hacker, David L.
    Cohen, Leonard
    Muller, Natahe
    Thanh, Huy-Phan
    Derow, Elisabeth
    Ritter, Gerd
    Wurm, Florian M.
    CELL TECHNOLOGY FOR CELL PRODUCTS, 2007, : 455 - +
  • [6] Development of a transient mammalian expression process for the production of the cancer testis antigen NY-ESO-1
    Hacker, David L.
    Cohen, Leonard
    Muller, Natalie
    Thanh, Huy-Phan
    Derow, Elisabeth
    Ritter, Gerd
    Wurm, Florian M.
    CELL TECHNOLOGY FOR CELL PRODUCTS, 2007, : 125 - +
  • [7] NY-ESO-1:: Review of an immunogenic tumor antigen
    Gnjatic, Sacha
    Nishikawa, Hiroyoshi
    Jungbluth, Achim A.
    Guere, Ali O.
    Ritter, Gerd
    Jaeger, Elke
    Chen, Yao-Tseng
    Old, Lloyd J.
    ADVANCES IN CANCER RESEARCH, VOL 95, 2006, 95 : 1 - 30
  • [8] Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
    Chu, Hin Lun
    Cornelissen, Bart
    Jackson, Mark
    Vallis, Katherine
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis
    Smith, Stephen M.
    Iwenofu, O. Hans
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (04)
  • [10] A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression
    Gunda, Viswanath
    Frederick, Dennie T.
    Bernasconi, Maria J.
    Wargo, Jennifer A.
    Parangi, Sareh
    THYROID, 2014, 24 (08) : 1241 - 1250